| Shawna Kay Mccalip, MD | |
|
2617 S Elm Pl, Broken Arrow, OK 74012-7850 | |
| (918) 455-6980 | |
| (918) 449-9743 |
| Full Name | Shawna Kay Mccalip |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 2617 S Elm Pl, Broken Arrow, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326052697 | NPI | - | NPPES |
| 100090520A | Medicaid | OK | |
| P00378363 | Other | OK | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 20291 (Oklahoma) | Primary |
| Entity Name | St John Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336194406 PECOS PAC ID: 2567366495 Enrollment ID: O20031121000867 |
News Archive
To address the underlying autoimmune process that is central to type 1 diabetes (T1D), JDRF and Novo Nordisk are partnering to discover and develop novel immunotherapies to prevent, treat, and help cure the disease.
Lesbian, gay, bisexual, and transgender (LGBT) migrants who obtained refuge or asylum in the U.S. or Canada on the basis of sexual orientation or gender identity report extensive recollections of abuse by parents and caregivers, peers and school personnel, according to a new Rutgers study.
OrbusNeich Medical, Inc., a designer, developer, manufacturer and marketer of innovative medical devices for the treatment of cardiovascular diseases, today announced that on March 23, 2010, the Company was granted U.S. Patent No. 7,682,384 B2, entitled "Stent with Helical Elements." The patent relates to an expandable stent comprised of a plurality of helical segments. The Company noted that it has identified unlicensed use by Boston Scientific Corporation of certain technologies protected under U.S. Patent No. 7,682,384 B2.
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, today announced that it will be presenting today, at the Annual Meeting of the Congress of Neurological Surgeons in New Orleans, Louisiana at 3:15pm central time, data from its Phase I clinical trial investigating the role that its ICT-107 vaccine may play in increasing patient survival and inhibiting tumor progression in patients with glioblastoma, the most common and most aggressive type of primary brain tumor.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shawna Kay Mccalip, MD 1145 S Utica Ave, Suite 110, Tulsa, OK 74104-4000 Ph: (918) 579-3826 | Shawna Kay Mccalip, MD 2617 S Elm Pl, Broken Arrow, OK 74012-7850 Ph: (918) 455-6980 |
News Archive
To address the underlying autoimmune process that is central to type 1 diabetes (T1D), JDRF and Novo Nordisk are partnering to discover and develop novel immunotherapies to prevent, treat, and help cure the disease.
Lesbian, gay, bisexual, and transgender (LGBT) migrants who obtained refuge or asylum in the U.S. or Canada on the basis of sexual orientation or gender identity report extensive recollections of abuse by parents and caregivers, peers and school personnel, according to a new Rutgers study.
OrbusNeich Medical, Inc., a designer, developer, manufacturer and marketer of innovative medical devices for the treatment of cardiovascular diseases, today announced that on March 23, 2010, the Company was granted U.S. Patent No. 7,682,384 B2, entitled "Stent with Helical Elements." The patent relates to an expandable stent comprised of a plurality of helical segments. The Company noted that it has identified unlicensed use by Boston Scientific Corporation of certain technologies protected under U.S. Patent No. 7,682,384 B2.
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, today announced that it will be presenting today, at the Annual Meeting of the Congress of Neurological Surgeons in New Orleans, Louisiana at 3:15pm central time, data from its Phase I clinical trial investigating the role that its ICT-107 vaccine may play in increasing patient survival and inhibiting tumor progression in patients with glioblastoma, the most common and most aggressive type of primary brain tumor.
› Verified 5 days ago
Dr. James Michael Ritze, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3100 S Elm Pl, Suite C, Broken Arrow, OK 74012 Phone: 918-451-9988 | |
Sujan Joshi, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2617 S Elm Pl, Broken Arrow, OK 74012 Phone: 918-455-4541 Fax: 918-449-9743 | |
Robert Jeffrey Wright, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 W Boise Cir Ste 160, Broken Arrow, OK 74012 Phone: 918-994-9160 Fax: 918-403-6306 | |
Christina Jane Clark, PA Family Medicine Medicare: Medicare Enrolled Practice Location: 705 W Oakland St, Broken Arrow, OK 74012 Phone: 918-251-2666 | |
Christopher Jason Guinn, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 2617 S Elm Pl Ste 100, Broken Arrow, OK 74012 Phone: 918-455-4541 Fax: 918-449-9743 | |
Bart Rider, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 2950 S Elm Pl, Ste 160, Broken Arrow, OK 74012 Phone: 918-449-3750 Fax: 918-449-3755 | |
Dr. Jefferey L Davis, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2021 S Elm Place, Broken Arrow, OK 74012 Phone: 918-806-6461 Fax: 918-806-6710 |